AdamsHPJrdel ZoppoGAlbertsMJ. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation2007; 115: e478–e534.
2.
LevyDEBrottTGHaleyECJr. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke1994; 25: 291–297.
3.
BreuerLNoweTHuttnerHB. Weight approximation in stroke before thrombolysis: the WAIST-Study: a prospective observational “dose-finding” study. Stroke2010; 41: 2867–2871.
4.
Garcia-PastorADiaz-OteroFFunes-MolinaC. Tissue plasminogen activator for acute ischemic stroke: calculation of dose based on estimated patient weight can increase the risk of cerebral bleeding. J Thromb Thrombolysis2015; 40: 347–352.
HackeWKasteMFieschiC. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA1995; 274: 1017–1025.
